Japan industry group to examine clinical site cost discrepancies

By Gareth Macdonald

- Last updated on GMT

© Getty Images / itasun
© Getty Images / itasun

Related tags Clinical trial

Japanese industry group JPMA has opted for cloud-based tech to help it understand why the cost of running a trial in the country varies depending on the site involved.

The Japan Pharmaceutical Manufacturers Association (JPMA) announced the project today, explaining that it will use Medidata software to model site-to-site cost variation and compare the findings with data from the UK, the US and 17 Asia-Pacific countries.

The collaboration follows a JPMA report (here​ in Japanese) highlighting the various cost calculations and payment methods in use at different investigator sites, which it suggests are holding back drug development in the country.

Shingo Haseto, leader of the JPMA’s clinical evaluation taskforce, said: “As the Japanese clinical trial landscape evolves, it is increasingly important that we ensure consistent and fair payment—both for sponsors and sites.”

He added that a better understanding of the cost discrepancies will result in “increased transparency around clinical trial costs related to site performance.”


Japan has its own good clinical practice standard – J-GCP – which while similar to International Conference on Harmonisation GCP standards (ICH-GCP) differ in some key respects​.

The key differences – as they apply to trial sites in Japan – is the requirement that, in most cases, sites have their own institutional review board and the rule that site heads are responsible for signing all financial contracts.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more